Five Prime Therapeutics Inc (FPRX) Return on Assets ROA from the fourth quarter of 2020 to fourth quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Dec 31 2020 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Five Prime Therapeutics Inc   (NASDAQ: FPRX)


Five Prime Therapeutics Inc 's ROA from the fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Five Prime Therapeutics Inc 's ROA in the fourth quarter of 2020?
Five Prime Therapeutics Inc recorded a cumulative net loss of $-84 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on assets (ROA) of -41.51%.

However, within the Healthcare sector 568 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2020 from 4149 to 4536.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Total Assets Change 38.58 % -44.85 % -46.3 % -35.83 % -30.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -84 -95 -104 -122 -137
Return On Assets (TTM) -41.51 % -52.24 % -49.63 % -49.91 % -50.33 %
FPRX's Total Ranking # 4536 # 4149 # 4156 # 4241 # 4753
Total Assets (TTM) in million 311 143 157 203 224
Seq. Total Assets Change 117.83 % -9.08 % -22.57 % -9.63 % -13.3 %
Seq. Net Income Change - - - - -

FPRX's 5 Years Annual ROA >> Back to FPRX Management Effectiveness >> Compare FPRX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 240
Sector # 569
Overall # 4405

Return On Assets Statistics
High Average Low
84.39 %
-42.55 %
-276.18 %
(Dec 31 2015)   (Mar 31 2014)





Financial Statements
Five Prime Therapeutics Inc 's Assets $ 311 million FPRX's Balance sheet
Five Prime Therapeutics Inc 's Income $ -21 million Quarterly FPRX's Income Statement
FPRX's Income by Division See FPRX's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change 38.58 % -30.29 % -6.54 % -23.25 % -18.24 %
Total Assets in million 311 224 322 344 448
Y / Y Net Income Change - - - - -
Net Income in million -84 -137 -140 -150 -66
Annual Return On Assets -27.15 % -61.21 % -43.68 % -43.66 % -14.66 %

FPRX's 5 Years Annual ROA >> Back to FPRX Management Effectiveness >> Compare FPRX ROA to its Competitors



More Return On Assets Ratios
FPRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FPRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FPRX's Competitors
Subscribers only: Roa for Five Prime Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for FPRX's Customers

You may also want to know
FPRX's Roi FPRX's Inventory Turnover Ratio FPRX's Growth Rates FPRX's Dividend Comparisons
FPRX's Profitability Ratios FPRX's Asset Turnover Ratio FPRX's Dividend Growth
FPRX's Roe FPRX's Valuation Ratios FPRX's Financial Strength Ratios FPRX's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2020, within Healthcare Sector ROA

Date modified: 2026-06-22T14:32:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.